The Effect of Body Mass Index Class on Patient-Reported Health-Related Quality of Life Before and After Total Hip Arthroplasty for Osteoarthritis: Registry-Based Cohort Study of 64,055 Patients.
Journal
JB & JS open access
ISSN: 2472-7245
Titre abrégé: JB JS Open Access
Pays: United States
ID NLM: 101726219
Informations de publication
Date de publication:
Historique:
entrez:
23
12
2020
pubmed:
24
12
2020
medline:
24
12
2020
Statut:
epublish
Résumé
Overweight status and obesity represent a global epidemic, with serious consequences at the individual and community levels. The number of total hip arthroplasties (THAs) among overweight and obese patients is expected to rise. Increasing body mass index (BMI) has been associated with a higher risk of mortality and reoperation and lower implant survival. The evaluation of perioperative health-related quality of life (HRQoL) has recently gained importance because of its direct relation to, and impact on, patients' physical, mental, and social well-being as well as health-service utilization. We sought to evaluate the influence of BMI class on HRQoL preoperatively and at 1 year following THA in a register-based cohort study. This observational cohort study was designed and conducted on the basis of registry data derived from the Swedish Hip Arthroplasty Register (SHAR) and included 64,055 primary THAs registered between January 1, 2008, and December 31, 2015. Patients' baseline preoperative and 1-year postoperative EuroQol-5 Dimension-3 Level (EQ-5D-3L) responses were documented by the treating department and reported to the SHAR through the patient-reported outcome measures program. The EQ-5D-3L includes a visual analogue scale (EQ VAS), which measures the patient's overall health status. At 1 year of follow-up, all BMI classes showed significant and clinically relevant improvements in all HRQoL measures compared with preoperative assessment (p < 0.05). Patients reported improved perception of current overall health status for the EQ VAS. Underweight, overweight, and all obesity classes showed increasingly worse 1-year HRQoL compared with normal weight, both with unadjusted and adjusted calculations. In this study, we found that all BMI classes had significant improvement in HRQoL at 1 year following THA. Patients who were underweight, overweight, or obese (classes I to III), compared with those of normal weight, reported worse hip pain and EQ-5D-3L and EQ VAS responses prior to THA and at 1 year postoperatively. These results can assist both health-care providers and patients in establishing reasonable expectations about THA outcomes. Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Sections du résumé
BACKGROUND
BACKGROUND
Overweight status and obesity represent a global epidemic, with serious consequences at the individual and community levels. The number of total hip arthroplasties (THAs) among overweight and obese patients is expected to rise. Increasing body mass index (BMI) has been associated with a higher risk of mortality and reoperation and lower implant survival. The evaluation of perioperative health-related quality of life (HRQoL) has recently gained importance because of its direct relation to, and impact on, patients' physical, mental, and social well-being as well as health-service utilization. We sought to evaluate the influence of BMI class on HRQoL preoperatively and at 1 year following THA in a register-based cohort study.
METHODS
METHODS
This observational cohort study was designed and conducted on the basis of registry data derived from the Swedish Hip Arthroplasty Register (SHAR) and included 64,055 primary THAs registered between January 1, 2008, and December 31, 2015. Patients' baseline preoperative and 1-year postoperative EuroQol-5 Dimension-3 Level (EQ-5D-3L) responses were documented by the treating department and reported to the SHAR through the patient-reported outcome measures program. The EQ-5D-3L includes a visual analogue scale (EQ VAS), which measures the patient's overall health status.
RESULTS
RESULTS
At 1 year of follow-up, all BMI classes showed significant and clinically relevant improvements in all HRQoL measures compared with preoperative assessment (p < 0.05). Patients reported improved perception of current overall health status for the EQ VAS. Underweight, overweight, and all obesity classes showed increasingly worse 1-year HRQoL compared with normal weight, both with unadjusted and adjusted calculations.
CONCLUSIONS
CONCLUSIONS
In this study, we found that all BMI classes had significant improvement in HRQoL at 1 year following THA. Patients who were underweight, overweight, or obese (classes I to III), compared with those of normal weight, reported worse hip pain and EQ-5D-3L and EQ VAS responses prior to THA and at 1 year postoperatively. These results can assist both health-care providers and patients in establishing reasonable expectations about THA outcomes.
LEVEL OF EVIDENCE
METHODS
Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Identifiants
pubmed: 33354639
doi: 10.2106/JBJS.OA.20.00100
pii: JBJSOA-D-20-00100
pmc: PMC7748188
pii:
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
Copyright © 2020 The Authors. Published by The Journal of Bone and Joint Surgery, Incorporated. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors indicated that no external funding was received for any aspect of this work. On the Disclosure of Potential Conflicts of Interest forms, which are provided with the online version of the article, one or more of the authors checked “yes” to indicate that the author had a relevant financial relationship in the biomedical arena outside the submitted work (http://links.lww.com/JBJSOA/A240).
Références
J Arthroplasty. 2012 Mar;27(3):391-6
pubmed: 21802250
EFORT Open Rev. 2018 Sep 24;3(9):507-512
pubmed: 30305935
Bone Joint J. 2017 Jan;99-B(1 Supple A):31-36
pubmed: 28042116
Cell Microbiol. 2014 Oct;16(10):1484-92
pubmed: 25073615
Obes Surg. 2012 Apr;22(4):523-9
pubmed: 21800224
Eur Spine J. 2019 Feb;28(2):214-223
pubmed: 30324498
Clin Geriatr Med. 2012 Aug;28(3):395-429
pubmed: 22840305
Obesity (Silver Spring). 2007 Nov;15(11):2840-5
pubmed: 18070776
Obesity (Silver Spring). 2013 Mar;21(3):E322-7
pubmed: 23592685
Obes Rev. 2017 Jul;18(7):715-723
pubmed: 28489290
Scand J Work Environ Health. 2013 May 1;39(3):233-40
pubmed: 23460255
Acta Orthop. 2016 Jul;87 Suppl 1:9-23
pubmed: 27228230
Med Care. 1997 Nov;35(11):1095-108
pubmed: 9366889
Br J Pharmacol. 2018 May;175(10):1569-1579
pubmed: 29486050
J Bone Joint Surg Br. 2008 Apr;90(4):424-9
pubmed: 18378913
Obes Res. 2001 Mar;9(3):219-23
pubmed: 11323448
J Orthop Surg Res. 2012 Apr 25;7:16
pubmed: 22533938
J Bone Joint Surg Br. 2011 Jul;93(7):867-75
pubmed: 21705555
Orthop Clin North Am. 2018 Jul;49(3):291-296
pubmed: 29929710
J Bone Joint Surg Br. 2006 Oct;88(10):1286-92
pubmed: 17012415
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33
pubmed: 24625040
J Arthroplasty. 2017 Jan;32(1):143-149
pubmed: 27499520
Acta Orthop. 2019 Jun;90(3):220-225
pubmed: 30931664
Nutrients. 2014 Nov 18;6(11):5153-83
pubmed: 25412152
Mol Cells. 2014 May;37(5):365-71
pubmed: 24781408
J Orthop Res. 2018 Feb;36(2):594-604
pubmed: 29080354
Acta Orthop. 2020 Jun;91(3):272-278
pubmed: 32237930
J Bone Joint Surg Br. 2008 Mar;90(3):360-3
pubmed: 18310761
J Pain Res. 2015 Jul 14;8:399-408
pubmed: 26203274
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
J Arthroplasty. 2015 Feb;30(2):165-70
pubmed: 25267536
Nat Rev Endocrinol. 2019 May;15(5):288-298
pubmed: 30814686
Acta Orthop. 2013 Aug;84(4):392-7
pubmed: 23992141
J Bone Joint Surg Br. 1996 Jan;78(1):78-81
pubmed: 8898132
Psychosomatics. 2013 Mar-Apr;54(2):149-57
pubmed: 23194934
Nat Rev Immunol. 2006 Oct;6(10):772-83
pubmed: 16998510
BMJ Open. 2018 Feb 27;8(2):e017689
pubmed: 29487072
Ann Rheum Dis. 2005 Jan;64(1):29-33
pubmed: 15208174
Clin Obes. 2017 Oct;7(5):273-289
pubmed: 28695722
J Arthroplasty. 2018 Jul;33(7S):S71-S75.e2
pubmed: 29567002